Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

752
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
752
Glaucoma: Overview01:25

Glaucoma: Overview

973
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
973
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

889
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
889
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

20
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
20
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.8K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

566
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
566

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Role of point-by-point light sensitivity in the assessment of glaucoma progression].

Vestnik oftalmologii·2024
Same author

[Minoxidil-induced ophthalmic hypertension (case report)].

Vestnik oftalmologii·2024
Same author

[The effect of keratoconus-associated refractive errors on the results of tomographic methods of studying the posterior structures of the eye].

Vestnik oftalmologii·2023
Same author

[Static automated perimetry in the diagnosis of glaucoma. Assessment of disease progression].

Vestnik oftalmologii·2023
Same author

[Modern achievements in the diagnosis and treatment of glaucoma].

Vestnik oftalmologii·2023
Same author

[Comparative evaluation of hypotensive effectiveness of topical monotherapy and selective laser trabeculectomy].

Vestnik oftalmologii·2022

Related Experiment Video

Updated: Oct 16, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.6K

[Challenges of long-term glaucoma therapy].

V P Erichev1

  • 1Research Institute of Eye Diseases, Moscow, Russia.

Vestnik Oftalmologii
|October 20, 2021
PubMed
Summary

Primary open-angle glaucoma (POAG) management faces challenges with long-term topical treatments causing adverse events and compliance issues. New treatment paradigms are needed to improve outcomes for this common cause of irreversible vision loss.

Keywords:
adverse eventscomplianceglaucomaglaucoma surgeryintraocular pressurequality of lifetopical therapy

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.3K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.5K

Related Experiment Videos

Last Updated: Oct 16, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.6K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.3K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.5K

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Medical Science

Background:

  • Primary open-angle glaucoma (POAG) is a leading cause of irreversible vision loss.
  • POAG pathogenesis involves complex mechanical, hemodynamic, and metabolic factors.
  • Current treatment focuses on lowering intraocular pressure (IOP) via topical antihypertensive therapy.

Purpose of the Study:

  • To highlight the limitations of current POAG treatment strategies.
  • To underscore the need for evolving the therapeutic paradigm for POAG.
  • To address challenges associated with long-term topical glaucoma management.

Main Methods:

  • Review of current ophthalmological practices in POAG management.
  • Analysis of the difficulties and adverse events associated with lifelong topical therapy.
  • Examination of factors impacting patient compliance and quality of life.

Main Results:

  • Long-term topical therapy for POAG presents significant challenges.
  • Consistent IOP normalization, adverse events, and patient compliance are major issues.
  • Current treatment approaches can lead to decreased quality of life and increased surgical risks.

Conclusions:

  • The established treatment paradigm for POAG requires re-evaluation.
  • There is a critical need for innovative approaches to POAG management.
  • Shifting the treatment paradigm is essential for improving patient outcomes and quality of life.